한글목차

세계의 이식형 중심정맥 포트 시장 규모는 2024년에 5억 6,500만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 2.7%로 성장하여 2031년까지 6억 8,000만 달러로 확대될 것으로 예측됩니다.

본 보고서에서는 최근 임베디드 정맥 액세스 포트에 대한 관세 조정과 국제적인 전략적 대응 조치에 대해 국경 간 산업적 발자취, 자본 배분 패턴, 지역 경제의 상호의존성, 공급망 재구성 등의 관점에서 종합적인 평가를 제공합니다.

이식형 중심정맥 포트는 일반적으로 흉부 또는 상완부에 외과적으로 이식되는 소형 의료기기로, 약물, 수액, 혈액 제제 투여 또는 채혈을 위한 장기 정맥 접근을 제공합니다. 이는 대정맥에 삽입되는 카테터와 연결된 저류부(포트)로 구성되어 있습니다. 화학요법, 장기 항생제 치료, 완전 정맥영양요법을 받는 환자들에게 자주 사용되며, 잦은 주사바늘 삽입에 따른 불편함과 위험을 최소화하면서 반복적인 혈류 접근을 가능하게 합니다.

이식형 중심정맥 포트 시장은 암, 만성 감염, 소화기 질환 등 장기적인 정맥 내 치료가 필요한 만성 질환 증가에 힘입어 괄목할 만한 성장을 보이고 있습니다. 특히 고령화 사회에서 전 세계적으로 암 발생률이 증가함에 따라 화학요법을 위한 신뢰할 수 있는 장기 혈관 접근에 대한 필요성이 크게 증가하고 있습니다. 이식형 포트는 기존 말초 라인에 비해 감염 위험 감소, 환자 편의성 향상, 장기적인 비용 효율성 향상 등의 장점이 있어 많은 임상 현장에서 우선적으로 선택되고 있습니다. 또한, 소형화, MRI 대응, 생체적합성 향상 등 포트 설계의 발전으로 임상적 성과와 환자 수용성이 향상되고 있습니다. 신흥 경제국의 의료 인프라 확충과 의사와 환자 모두에게 이식형 포트의 장점에 대한 인식이 높아진 것도 보급을 촉진하고 있습니다. 또한, 선진국 시장의 의료비 지출 증가와 지원적인 상환 정책은 이러한 장치의 광범위한 사용에 적합한 환경을 제공합니다.

수요 증가에도 불구하고 임플란트 정맥 접근 포트 시장은 몇 가지 중요한 문제에 직면해 있습니다. 주요 장벽 중 하나는 기기 자체의 높은 초기 비용과 임플란트에 필요한 외과적 시술로, 의료 예산이 제한된 중저소득 국가에서는 접근성이 제한될 수 있습니다. 또한, 이식 수술과 감염, 혈전증, 기기 고장 등 포트 관련 합병증을 관리하기 위해서는 숙련된 의료진이 필요하며, 충분한 훈련과 자원이 부족한 의료 시스템에는 부담이 될 수 있습니다. 또 다른 문제는 장기적인 합병증의 위험성입니다. 이로 인해 의사나 환자들은 꼭 필요한 경우가 아니라면 이 솔루션을 선택하는 것을 주저할 수 있습니다. 새로운 의료기기의 규제 장벽과 승인 과정의 장기화도 첨단 기술 시장 침투를 지연시키는 요인으로 작용합니다. 또한, 외래진료나 재택의료 현장에서는 이식형 포트 관리에 대한 적절한 교육과 위생관리가 필요하며, 이를 소홀히 할 경우 부작용의 위험이 높아질 수 있습니다. 이러한 기술적, 경제적, 규제적 문제를 해결하는 것이 임플란트 정맥 접근 포트의 세계 보급을 촉진하고 임상적 이점을 극대화하는 데 필수적입니다.

이 보고서는 임베디드 정맥 액세스 포트 세계 시장에 대해 총 판매량, 매출, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목표로 합니다.

이식형 중심정맥 포트 시장 규모 추정 및 예측은 판매량(천 단위) 및 매출액(백만 달러)으로 제시되며, 2024년을 기준 연도로 하여 2020-2031년의 과거 데이터와 예측 데이터를 포함하는 2024년부터 2031년까지의 예측 데이터를 제공합니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 이식형 중심정맥 포트에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.

시장 세분화

기업별

• BD
• AngioDynamics
• ICU Medical
• B. Braun Medical
• PFM Medical
• Vygon
• Districlass
• PakuMed
• Linhua Medical
• Fresenius
• Sophysa
• Baxter

유형별 부문

• 티타늄 주입 포트
• 플라스틱 주입 포트

용도별 부문

• 정맥내 화학요법
• 영양 지원 치료

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동 및 아프리카

영문목차

The global market for Implantable Venous Access Port was estimated to be worth US$ 565 million in 2024 and is forecast to a readjusted size of US$ 680 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Implantable Venous Access Port cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

An Implantable Venous Access Port is a small medical device surgically placed under the skin, typically in the chest or upper arm, that provides long-term venous access for the administration of medications, fluids, blood products, or for blood withdrawal. It consists of a reservoir (port) connected to a catheter that is inserted into a large central vein. Commonly used in patients undergoing chemotherapy, long-term antibiotic therapy, or total parenteral nutrition, the port allows repeated access to the bloodstream while minimizing the discomfort and risk associated with frequent needle sticks.

The market for implantable venous access ports is experiencing strong growth driven by the increasing prevalence of chronic diseases that require long-term intravenous therapy, such as cancer, chronic infections, and gastrointestinal disorders. With the global rise in cancer incidence, particularly among aging populations, the need for reliable and long-term vascular access for chemotherapy has grown substantially. Implantable ports offer advantages over traditional peripheral lines, including reduced risk of infection, improved patient comfort, and better long-term cost efficiency, making them the preferred choice in many clinical settings. Additionally, advancements in port design, such as smaller sizes, MRI compatibility, and improved biocompatibility, are enhancing clinical outcomes and patient acceptance. The expansion of healthcare infrastructure in emerging economies, combined with greater awareness among physicians and patients regarding the benefits of implantable ports, is also fueling adoption. Furthermore, rising healthcare expenditure and supportive reimbursement policies in developed markets provide a conducive environment for the widespread use of these devices.

Despite the growing demand, the implantable venous access port market faces several significant challenges. One major barrier is the high upfront cost of the devices and the surgical procedures required for implantation, which may limit access in low- and middle-income countries with constrained healthcare budgets. Additionally, the need for skilled healthcare professionals to perform the implantation and manage port-related complications, such as infections, thrombosis, or device malfunction, can strain healthcare systems lacking sufficient training or resources. Another challenge is the risk of long-term complications, which may deter physicians or patients from opting for this solution unless absolutely necessary. Regulatory hurdles and lengthy approval processes for new device innovations can also slow down market penetration for advanced technologies. Moreover, in outpatient and home-care settings, the management of implantable ports requires proper training and hygiene practices, which, if neglected, could increase the risk of adverse events. These technical, economic, and regulatory obstacles must be addressed to ensure broader accessibility and to maximize the clinical benefits of implantable venous access ports globally.

This report aims to provide a comprehensive presentation of the global market for Implantable Venous Access Port, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Implantable Venous Access Port by region & country, by Type, and by Application.

The Implantable Venous Access Port market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Venous Access Port.

Market Segmentation

By Company

• BD
• AngioDynamics
• ICU Medical
• B. Braun Medical
• PFM Medical
• Vygon
• Districlass
• PakuMed
• Linhua Medical
• Fresenius
• Sophysa
• Baxter

Segment by Type

• Titanium Infusion Port
• Plastic Infusion Port

Segment by Application

• Intravenous Chemotherapy
• Nutritional Support Treatment

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Implantable Venous Access Port manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Implantable Venous Access Port in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Implantable Venous Access Port in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Implantable Venous Access Port Product Introduction
• 1.2 Global Implantable Venous Access Port Market Size Forecast
  • 1.2.1 Global Implantable Venous Access Port Sales Value (2020-2031)
  • 1.2.2 Global Implantable Venous Access Port Sales Volume (2020-2031)
  • 1.2.3 Global Implantable Venous Access Port Sales Price (2020-2031)
• 1.3 Implantable Venous Access Port Market Trends & Drivers
  • 1.3.1 Implantable Venous Access Port Industry Trends
  • 1.3.2 Implantable Venous Access Port Market Drivers & Opportunity
  • 1.3.3 Implantable Venous Access Port Market Challenges
  • 1.3.4 Implantable Venous Access Port Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Implantable Venous Access Port Players Revenue Ranking (2024)
• 2.2 Global Implantable Venous Access Port Revenue by Company (2020-2025)
• 2.3 Global Implantable Venous Access Port Players Sales Volume Ranking (2024)
• 2.4 Global Implantable Venous Access Port Sales Volume by Company Players (2020-2025)
• 2.5 Global Implantable Venous Access Port Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Implantable Venous Access Port Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Implantable Venous Access Port Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Implantable Venous Access Port
• 2.9 Implantable Venous Access Port Market Competitive Analysis
  • 2.9.1 Implantable Venous Access Port Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Implantable Venous Access Port Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Venous Access Port as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Titanium Infusion Port
  • 3.1.2 Plastic Infusion Port
• 3.2 Global Implantable Venous Access Port Sales Value by Type
  • 3.2.1 Global Implantable Venous Access Port Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Implantable Venous Access Port Sales Value, by Type (2020-2031)
  • 3.2.3 Global Implantable Venous Access Port Sales Value, by Type (%) (2020-2031)
• 3.3 Global Implantable Venous Access Port Sales Volume by Type
  • 3.3.1 Global Implantable Venous Access Port Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Implantable Venous Access Port Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Implantable Venous Access Port Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Implantable Venous Access Port Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Intravenous Chemotherapy
  • 4.1.2 Nutritional Support Treatment
• 4.2 Global Implantable Venous Access Port Sales Value by Application
  • 4.2.1 Global Implantable Venous Access Port Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Implantable Venous Access Port Sales Value, by Application (2020-2031)
  • 4.2.3 Global Implantable Venous Access Port Sales Value, by Application (%) (2020-2031)
• 4.3 Global Implantable Venous Access Port Sales Volume by Application
  • 4.3.1 Global Implantable Venous Access Port Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Implantable Venous Access Port Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Implantable Venous Access Port Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Implantable Venous Access Port Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Implantable Venous Access Port Sales Value by Region
  • 5.1.1 Global Implantable Venous Access Port Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Implantable Venous Access Port Sales Value by Region (2020-2025)
  • 5.1.3 Global Implantable Venous Access Port Sales Value by Region (2026-2031)
  • 5.1.4 Global Implantable Venous Access Port Sales Value by Region (%), (2020-2031)
• 5.2 Global Implantable Venous Access Port Sales Volume by Region
  • 5.2.1 Global Implantable Venous Access Port Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Implantable Venous Access Port Sales Volume by Region (2020-2025)
  • 5.2.3 Global Implantable Venous Access Port Sales Volume by Region (2026-2031)
  • 5.2.4 Global Implantable Venous Access Port Sales Volume by Region (%), (2020-2031)
• 5.3 Global Implantable Venous Access Port Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Implantable Venous Access Port Sales Value, 2020-2031
  • 5.4.2 North America Implantable Venous Access Port Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Implantable Venous Access Port Sales Value, 2020-2031
  • 5.5.2 Europe Implantable Venous Access Port Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Implantable Venous Access Port Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Implantable Venous Access Port Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Implantable Venous Access Port Sales Value, 2020-2031
  • 5.7.2 South America Implantable Venous Access Port Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Implantable Venous Access Port Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Implantable Venous Access Port Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Implantable Venous Access Port Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Implantable Venous Access Port Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Implantable Venous Access Port Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Implantable Venous Access Port Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Implantable Venous Access Port Sales Value, 2020-2031
  • 6.3.2 United States Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Implantable Venous Access Port Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Implantable Venous Access Port Sales Value, 2020-2031
  • 6.4.2 Europe Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Implantable Venous Access Port Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Implantable Venous Access Port Sales Value, 2020-2031
  • 6.5.2 China Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Implantable Venous Access Port Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Implantable Venous Access Port Sales Value, 2020-2031
  • 6.6.2 Japan Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Implantable Venous Access Port Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Implantable Venous Access Port Sales Value, 2020-2031
  • 6.7.2 South Korea Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Implantable Venous Access Port Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Implantable Venous Access Port Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Implantable Venous Access Port Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Implantable Venous Access Port Sales Value, 2020-2031
  • 6.9.2 India Implantable Venous Access Port Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Implantable Venous Access Port Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 BD
  • 7.1.1 BD Company Information
  • 7.1.2 BD Introduction and Business Overview
  • 7.1.3 BD Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 BD Implantable Venous Access Port Product Offerings
  • 7.1.5 BD Recent Development
• 7.2 AngioDynamics
  • 7.2.1 AngioDynamics Company Information
  • 7.2.2 AngioDynamics Introduction and Business Overview
  • 7.2.3 AngioDynamics Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 AngioDynamics Implantable Venous Access Port Product Offerings
  • 7.2.5 AngioDynamics Recent Development
• 7.3 ICU Medical
  • 7.3.1 ICU Medical Company Information
  • 7.3.2 ICU Medical Introduction and Business Overview
  • 7.3.3 ICU Medical Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 ICU Medical Implantable Venous Access Port Product Offerings
  • 7.3.5 ICU Medical Recent Development
• 7.4 B. Braun Medical
  • 7.4.1 B. Braun Medical Company Information
  • 7.4.2 B. Braun Medical Introduction and Business Overview
  • 7.4.3 B. Braun Medical Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 B. Braun Medical Implantable Venous Access Port Product Offerings
  • 7.4.5 B. Braun Medical Recent Development
• 7.5 PFM Medical
  • 7.5.1 PFM Medical Company Information
  • 7.5.2 PFM Medical Introduction and Business Overview
  • 7.5.3 PFM Medical Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 PFM Medical Implantable Venous Access Port Product Offerings
  • 7.5.5 PFM Medical Recent Development
• 7.6 Vygon
  • 7.6.1 Vygon Company Information
  • 7.6.2 Vygon Introduction and Business Overview
  • 7.6.3 Vygon Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Vygon Implantable Venous Access Port Product Offerings
  • 7.6.5 Vygon Recent Development
• 7.7 Districlass
  • 7.7.1 Districlass Company Information
  • 7.7.2 Districlass Introduction and Business Overview
  • 7.7.3 Districlass Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Districlass Implantable Venous Access Port Product Offerings
  • 7.7.5 Districlass Recent Development
• 7.8 PakuMed
  • 7.8.1 PakuMed Company Information
  • 7.8.2 PakuMed Introduction and Business Overview
  • 7.8.3 PakuMed Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 PakuMed Implantable Venous Access Port Product Offerings
  • 7.8.5 PakuMed Recent Development
• 7.9 Linhua Medical
  • 7.9.1 Linhua Medical Company Information
  • 7.9.2 Linhua Medical Introduction and Business Overview
  • 7.9.3 Linhua Medical Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Linhua Medical Implantable Venous Access Port Product Offerings
  • 7.9.5 Linhua Medical Recent Development
• 7.10 Fresenius
  • 7.10.1 Fresenius Company Information
  • 7.10.2 Fresenius Introduction and Business Overview
  • 7.10.3 Fresenius Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Fresenius Implantable Venous Access Port Product Offerings
  • 7.10.5 Fresenius Recent Development
• 7.11 Sophysa
  • 7.11.1 Sophysa Company Information
  • 7.11.2 Sophysa Introduction and Business Overview
  • 7.11.3 Sophysa Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Sophysa Implantable Venous Access Port Product Offerings
  • 7.11.5 Sophysa Recent Development
• 7.12 Baxter
  • 7.12.1 Baxter Company Information
  • 7.12.2 Baxter Introduction and Business Overview
  • 7.12.3 Baxter Implantable Venous Access Port Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Baxter Implantable Venous Access Port Product Offerings
  • 7.12.5 Baxter Recent Development

8 Industry Chain Analysis

• 8.1 Implantable Venous Access Port Industrial Chain
• 8.2 Implantable Venous Access Port Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Implantable Venous Access Port Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Implantable Venous Access Port Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer